Non-invasive Prenatal Testing Market Expected to Reach US$ 11.08 Billion by 2033
Non-invasive Prenatal Testing (NIPT) is a prenatal genetic assessment method that uses sophisticated DNA sequencing technologies to detect chromosomal abnormalities from maternal blood samples. Increasing healthcare investments in precision medicine and prenatal diagnostics continue to support market expansion. According to the Business Market Insights The Non-invasive Prenatal Testing Market...
0 Kommentare 0 Anteile 6 Ansichten 0 Vorschau